Pacira BioSciences: Pay

Pacira BioSciences paid its 8 named executives $32.2M in total in FY2024 (Dec). CEO Frank Lee was paid $15.9M of that.

Pay$100 in the stock at the end of FY23 → $56
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Frank LeeChief Executive Officer
FY2024 (Dec)
1 year
Kristen WilliamsChief Administrative Officer and Secretary
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Daryl GauglerExecutive Vice President, Commercial Operations
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
3 years
Jonathan SloninChief Medical Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Shawn CrossChief Financial Officer
FY2024 (Dec)
1 year
Lauren RikerFormer Interim Chief Financial Officer
FY2024 (Dec)
1 year
Charles A. Reinhart, IIIFormer Chief Financial Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
David StackFormer Chief Executive Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2023 (Dec), the median CEO pay of the 8 peers with pay on file was $10.6M. The CEO of Pacira BioSciences was paid $6.9M, 35% below the median.

  1. 1United Therapeutics
  2. 2Ultragenyx Pharmaceutical
  3. 3Ionis Pharmaceuticals
  4. 4Halozyme Therapeutics
  5. 5Alkermes plc.
  6. 6PTC Therapeutics
  7. 7Travere Therapeutics
  8. 8Pacira BioSciences
  9. 9CareDx
  10. 10Acadia PharmaceuticalsNot disclosed
  11. 11Amicus Therapeutics, Inc.Not disclosed
  12. 12Blueprint Medicines CorporationNot disclosed
  13. 13Corcept TherapeuticsNot disclosed
  14. 14Dynavax Technologies Corporation [img:ic_plus-pn]Not disclosed
  15. 15Emergent BioSolutions, Inc.Not disclosed
  16. 16ExelixisNot disclosed
  17. 17Ironwood Pharmaceuticals, Inc.Not disclosed
  18. 18Natera, Inc. [img:ic_plus-pn]Not disclosed
  19. 19Organogenesis Holdings, Inc.Not disclosed
  20. 20Sarepta Therapeutics, Inc. [img:ic_plus-pn]Not disclosed
  21. 21Supernus PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.